Jennifer Taylor

Jennifer Taylor has a diverse work experience in the field of clinical operations. Their most recent position is as the Director of Clinical Operations at LyGenesis, where they have been working since January 2022. Prior to that, they worked as a Senior Manager of Clinical Trials at the same company from June 2021 to January 2022.

Before LyGenesis, Jennifer held the role of Senior Manager of Clinical Operations at Currax Pharmaceuticals LLC from February 2020 to November 2020. Jennifer also worked as the Director of Clinical Operations at electroCore, Inc. from June 2018 to November 2019. Other roles they have held include Clinical Trial Operations Manager at R&D Partners from February 2018 to June 2018, Senior Clinical Manager at ExecuPharm from March 2016 to October 2016, and Clinical Trial Manager at Pearl Therapeutics from February 2015 to February 2016.

Jennifer's earlier experience includes roles such as Clinical Research Scientist at Regado Biosciences from September 2013 to October 2014, Clinical Research Project Manager at B. Braun Medical, Inc. from May 2011 to March 2013, Senior Clinical Study Associate at Stryker Spine from September 2008 to September 2010, and Trial Master File Coordinator (Regulatory Affairs) at i3 Research from April 2007 to July 2008. Overall, Jennifer has a strong background in clinical operations and has worked in various capacities throughout their career.

Jennifer Taylor completed their Associate degree in Arts at County College of Morris in an unspecified year, before attending Centenary University from 2001 to 2003. At Centenary University, they earned a Bachelor of Science degree in Psychology.